EcoDrugPlus

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSAMXG00000014384
Gene Symbol: GSK3A
3 Cross references
175 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSAMXG00000037552
Gene Symbol: GSK3A
3 Cross references
185 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSAMXG00000008836
Gene Symbol: GSK3B
3 Cross references
209 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSAMXG00000005487
Gene Symbol: LOC103043574
3 Cross references
164 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSAMXG00000014681
Gene Symbol: GNRHR1
1 Cross references
174 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSAMXG00000029545
Gene Symbol: LOC103037789
2 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSAMXG00000003721
Gene Symbol: GHSR
3 Cross references
143 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSAMXG00000006826
Gene Symbol: GUCY1A1
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSAMXG00000003757
Gene Symbol: GUCY1A2
2 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSAMXG00000006836
Gene Symbol: GUCY1B1
1 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSAMXG00000024526
Gene Symbol: HSP90AB1
3 Cross references
357 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1-Like

Ensembl ID : ENSAMXG00000020572
Gene Symbol: LOC103024139
4 Cross references
317 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).